Article Information
vol. 1 no. 1
PubMed
Published By
Online ISSN
History
- Received April 1, 2015
- Accepted April 3, 2015
- Published online May 6, 2015.
Copyright & Usage
The content of this work is ©the authors or their employers. Design and branding are ©ERS 2015 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0
Author Information
- Lia D'Ambrosio1,6,
- Rosella Centis1,6,
- Giovanni Sotgiu2,
- Emanuele Pontali3,
- Antonio Spanevello4,5 and
- Giovanni Battista Migliori1
- 1WHO Collaborating Centre for Tuberculosis & Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy
- 2Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy
- 3Department of Infectious Diseases, Galliera Hospital, Genoa, Italy
- 4Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy
- 5Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
- 6These authors contributed equally
- Giovanni Battista Migliori, World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Via Roncaccio 16, 21049, Tradate, Italy. E-mail: giovannibattista.migliori{at}fsm.it
Article usage
Altmetrics
Vol 1 Issue 1
Table of Contents
New anti-tuberculosis drugs and regimens: 2015 update
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Designing a regimen to treat TB
- Designing a regimen to treat MDR-TB
- Improving the individualised approach to drug dosing: TDM
- Improving the clinical management of MDR/XDR-TB: the European Respiratory Society/WHO TB Consilium
- The pipeline to design new regimens
- Conclusions
- Footnotes
- References
- Figures & Data
- Info & Metrics